MarketBeat provided analyst recommendations and compared investment factors for Addex Therapeutics and XORTX Therapeutics.
3 reports, 3 independent
Updated Oct 14
Gone quiet
- Reports
- 3
- Developments
- 1
- Repetition
- 67%
New informationRepeats or wire copies
AI-generated analysis. Brind wrote this summary from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.
What happened
MarketBeat provided analyst recommendations and compared investment factors for Addex Therapeutics and XORTX Therapeutics.
Who's involved
What this event is mainly aboutKeep exploring
The entities involved
-
Addex Therapeutics
Swiss public company
Nothing else this week.
-
MarketBeat
American personal finance blog
Related events
- MarketBeat reported analyst recommendations for Cytokinetics and Gain Therapeutics, two competing healthcare companies.
- MarketBeat provided analyst recommendations and compared Organon & Co. and Xeris Biopharma.
- MarketBeat is comparing Lisata Therapeutics and Praxis Precision Medicines for investment and providing analyst ratings for Praxis.
- MarketBeat provided analyst ratings for technology companies Plexus and Cemtrex.
- TD Cowen upgraded Maze Therapeutics shares to a strong-buy rating, with coverage reported by MarketBeat.